Prostate Cancer Information

Selenium and Vitamins E and C Don’t Prevent Prostate Cancer (12/22/2008)
According to the results of two large randomized studies, selenium and vitamin E supplements do not reduce the risk of prostate cancer. These results were published in early online publications in the Journal of the American Medical Association on December 9, 2008.

Statins May Affect Prostate Specific Antigen Levels (11/12/2008)
Researchers from Duke University have reported that statin use lowers prostate specific antigen (PSA) levels and may interfere with the diagnosis of prostate cancer. The details of this study appeared in the November 5, 2008 issue of the Journal of the National Cancer Institute.

Avastin® May have Activity in Hormone-refractory Prostate Cancer (11/7/2008)
Researchers from Italy have reported that Avastin® (bevacizumab) plus docetaxel (Taxotere®) may have activity in patients with hormone-refractory prostate cancer (HRPC) who had previously been treated with Taxotere. The details of this study were reported in the November 2008 issue of European Urology.

High Volume Confirmed Important for Outcomes of Radical Prostatectomy (11/5/2008)
Researchers from the Minneapolis Veterans Affairs Center for Chronic Disease Outcomes research have reported that “higher provider volumes are associated with better outcomes after radical prostatectomy.” The details of this study were published in the September, 2008 issue of the Journal of Urology.

Agent Orange Exposure Increases the Incidence and Aggressiveness of Prostate Cancer (10/27/2008)
Researchers from the University of California Davis have reported that men exposed to Agent Orange in Vietnam have a two-fold increase in the incidence of prostate cancer, occurring at a younger age with a more aggressive histology than comparable men not exposed to Agent Orange. The details of this study were published in the November 1, 2008 issue of Cancer.